Contact LinkedIn Twitter
Cabaletta Bio, Inc.
  • Home
  • About
    • Overview
    • Leadership Team
    • Board of Directors
    • Scientific Advisory Board
    • Our Collaborators
    • Culture & Community
  • Technology
    • CABA® Platform
    • Posters & Publications
  • Pipeline
    • Overview
    • CABA-201
  • Patients
    • Overview
    • RESET-SLE™ Trial
    • RESET-Myositis™ Trial
    • RESET-SSc™ Trial
    • RESET-MG™ Trial
    • RESET-PV™ Trial
    • MusCAARTes™ Trial
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Analyst Coverage
    • Governance
  • Join Our Crew
  • Contact

Our RESETTM clinical trials with CABA-201 (investigational CD19-CAR T cell therapy) in lupus, myositis, systemic sclerosis, myasthenia gravis, and pemphigus vulgaris are now recruiting.

Sitemap

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
    • Our Collaborators
    • getReal
  • Technology
    • CABA® Platform
    • Posters & Publications
  • Pipeline
    • Overview
    • CABA-201
  • Patients
    • Overview
    • RESET-SLE™ Trial
    • RESET-Myositis™ Trial
    • RESET-SSc™ Trial
    • RESET-MG™ Trial
    • RESET-PV™ Trial
    • MusCAARTes™ Trial
    • Expanded Access Policy
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
      • Overview
      • Press Releases
      • IR Calendar
      • Email Alerts
    • Company Information
      • Overview
      • Management Team
      • Presentations
      • Contacts
      • FAQ
    • Financial Information
      • Overview
      • Financial Results
      • Income Statement
      • Balance Sheet
      • Cash Flow
    • Stock Data
      • Quote
      • Charts
      • Historical Data
    • SEC Filings
      • Overview
      • All SEC Filings
      • Annual Reports
      • Quarterly Reports
      • Section 16 Filings
    • Analyst Coverage
    • Corporate Governance
      • Overview
      • Board of Directors
      • Board Committees
      • Governance Documents
  • Join Our Crew
  • Contact
  • Disclaimer
  • Terms of Use
  • Sitemap
  • Privacy Notice
  • HR Privacy Notice (EU)
Cabaletta Bio, Inc.
  • About
  • Technology
  • Pipeline
  • Patients
  • News & Media
  • Investors
  • Join Our Crew

2929 Arch Street
Suite 600
Philadelphia, PA 19104

© 2025 Cabaletta Bio, Inc. All Rights Reserved.
Disclaimer Terms of Use Sitemap Privacy Notice HR Privacy Notice (EU)